KKKevin Kulshrestha

Kevin Kulshrestha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kevin Kulshrestha has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    National Experience With Tracheostomy in Neonates Undergoing Congenital Heart Surgery: A Multicenter Analysis

    by Hosam F. Ahmed, Muhammad Faateh, Kevin Kulshrestha, Spencer Hogue, David Cooper, Sara Zak, Awais Ashfaq, David Lehenbauer, David L. S. Morales, Alexis L. Benscoter

    OBJECTIVES: Our aim was to describe trends in tracheostomy utilization in infants requiring congenital heart surgery (CHS) during their index admission with specific focus on clinical and financial outcomes. DESIGN: A retrospective cohort study. SETTING: Data were obtained from the Pediatric Health Information System database. PATIENTS: Patients admitted as neonates (≤ 28 d) undergoing CHS with the use of cardiopulmonary bypass (CPB) during admission from 2004 to 2022 were identified. The cohort was divided into patients with vs. without tracheostomy. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We identified 13,415 neonatal admissions who underwent CHS with use of CPB, of which 391 (3%) underwent tracheostomy. Tracheostomy patients, compared with those without, were more likely to be female (46.8% vs. 40.0%; p = 0.007), of Black race (17.1% vs. 10.6%), preterm (29.2% vs. 14.1%), low birthweight (29.4% vs. 14.1%), had a higher frequency of chromosomal defects (23.5% vs. 8%), congenital airway (24% vs. 3.3%), and pulmonary (19.7% vs. 1.7%) abnormalities (all p < 0.001). Tracheostomy was associated with higher in-hospital mortality (23.8% vs. 8.6%), longer length of stay (183 vs. 26 d), higher cost of hospitalization ($1.2 vs. $0.2 million), and discharge to a location other than home (35.1% vs. 6.3%; all p < 0.001). Tracheostomy rates increased from 1.9% in 2004–2010 to 3% in 2017–2022 ( p = 0.002), while the in-hospital mortality in these patients was similar ( p = 0.72). CONCLUSIONS: The rate of tracheostomy placement in complex neonates and infants requiring CHS has increased in recent years. Patients with congenital airway or pulmonary abnormalities, cleft lip and/or palate, chromosomal disorders, and those requiring more than one surgery requiring CPB during admission were at greatest risk for tracheostomy placement. Tracheostomy is associated with longer ICU and hospital length of stay, six-fold increase in hospitalization cost, and higher rate of in-hospital mortality in our study population.

  • A Global Experience of Donation after Circulatory Death for Pediatric Lung Transplantation

    by Hosam F. Ahmed, Kevin Kulshrestha, Spencer Hogue, Monir Hossain, Yin Zhang, Wida S. Cherikh, Awais Ashfaq, David L. S. Morales, Don Hayes

    Rationale: Donation after circulatory death (DCD) lung transplantation (LT) has increased, but there are limited data in children. Objectives: We sought to characterize the international experience of pediatric DCD LT in comparison with donation after brain death (DBD) to address extreme donor organ shortages in children needing LT. Methods: Using the International Society for Heart & Lung Transplantation Thoracic Organ Transplant Registry, 1,453 children (<18 yr of age) lung transplant recipients from January 2004 to June 2018 were identified: 34 (3%) were DCD and 1,419 (97%) were DBD recipients. Post-transplantation outcomes were compared between groups. The propensity score method was used to derive matched cohorts, which were compared between groups. Results: DCD and DBD recipients were of similar age, with cystic fibrosis being the most frequent indication for LT in both groups (64.5% vs. 57.5%, respectively). Kaplan-Meier analysis demonstrated similar survival between the DCD and DBD cohorts, whereas propensity score–matched recipients also identified similar post-transplantation survival in both groups (P = 0.098). Secondary analysis revealed that DCD lung transplant recipients had a longer post-transplantation length of hospital stay (unmatched cohorts, 36.5 vs. 20 d [P = 0.022]; matched cohorts, 26 vs. 19 d [P = 0.016]) and shorter time to acute cellular rejection (unmatched cohorts, 248 vs. 560 d [P = 0.039]; matched cohorts, 248 vs. 1,650 d [P = 0.059]). Conclusions: Because DCD is a key contributor to the increasing number of LTs being performed worldwide, the results of this analysis support this organ donation approach in children requiring LT, which would increase access to donor organs. The identification of a potential shorter time to acute cellular rejection needs further exploration as more DCD pediatric LTs are performed.


  • Donation after circulatory death significantly reduces waitlist times while not changing post–heart transplant outcomes: A United Network for Organ Sharing Analysis

    by Hosam F. Ahmed, Kevin Kulshrestha, John T. Kennedy, Amalia Gomez-Guzman, Jason W. Greenberg, Monir Hossain, Yin Zhang, David A. D’aLessandro, Ranjit John, Nader Moazami, et al.


  • The majority of pediatric Fontan patients have excellent post-transplant survival

    by Kevin Kulshrestha, Jason W. Greenberg, John T. Kennedy, Spencer Hogue, David S. Winlaw, Awais Ashfaq, Farhan Zafar, David L.S. Morales


  • Reality of DCD donor use in pediatric thoracic transplantation in the United States

    by Hosam F. Ahmed, Amalia Guzman-Gomez, Kevin Kulshrestha, Eashwar C. Kantemneni, Clifford Chin, Awais Ashfaq, Farhan Zafar, David L.S. Morales


  • National experience with pediatric surgical aortic valve repair: A Pediatric Health Information System analysis

    by Kevin Kulshrestha, Jason W. Greenberg, John T. Kennedy, Spencer Hogue, Farhan Zafar, David Lehenbauer, David S. Winlaw, James A. Quintessenza, David L.S. Morales, Awais Ashfaq


  • Up to an Hour of Donor Resuscitation Does Not Affect Pediatric Heart Transplantation Survival

    by Kevin Kulshrestha, Jason W. Greenberg, Amalia M. Guzman-Gomez, John T. Kennedy, Monir Hossain, Yin Zhang, Farhan Zafar, David L.S. Morales


  • Not all durations of preheart transplant mechanical ventilation portend inferior post‐transplant survival in children

    by Jason W. Greenberg, Kevin Kulshrestha, Alia Dani, David S. Winlaw, David G. Lehenbauer, Clifford Chin, Angela Lorts, Katja M. Gist, Farhan Zafar, David L. S. Morales

    Background: Mechanical ventilation prior to pediatric heart transplantation predicts inferior post‐transplant survival, but the impact of ventilation duration on survival is unclear.Methods: Data from the United Network for Organ Sharing and Pediatric Health Information System were used to identify pediatric (5 weeks).Results: At transplant, 11% (511/4506) of patients required ventilation. Ventilated patients were younger, had more congenital heart disease, more urgent listing‐status, and greater rates of nephropathy, TPN‐dependence, and inotrope and ECMO requirements (p < .001 for all). Post‐transplant, previously ventilated patients experienced longer ventilation durations, ICU and hospital stays, and inferior survival (all p < .001). Hospital outcomes and survival worsened with longer pretransplant ventilation. One‐year and overall survival were similar between the no‐ventilation and ≤1 week groups (p = .703 & p = .433, respectively) but were significantly worse for ventilation durations >1 week (p < .001). On multivariable analysis, ventilation ≤1 week did not predict mortality (HR 0.98 [95% CI 0.85–1.43]), whereas ventilation >1 week did (HR: 1.18 [1.01–1.39]).Conclusions: Longer pretransplant ventilation portends worse outcomes, although only ventilation >1 week predicts mortality. These findings can inform pretransplant prognostication.


  • Female donor hearts can improve survival for male pediatric heart transplant recipients

    by Jason W. Greenberg, Ryan A. Moore, Kevin Kulshrestha, Angela Lorts, Tanya Perry, Bin Huang, Chen Chen, David L. S. Morales, Farhan Zafar

    Background: Both gender‐ and weight‐matching between donor and recipient are thought to impact survival in pediatric heart transplantation, with clinical dogma holding that male donor hearts and “ideal” weight‐matching yield superior survival. The composite impacts of gender and weight on post‐transplant survival (PTS) are understudied.Methods: All pediatric (age p < .001 vs. others) and lowest for undersized DRWR from either male or female donors (median 13.4 and 13.2 years; p < .001 vs. others). The majority (64%) of male recipients received ideal‐sized DRWR, among which female donor hearts yielded superior survival to males (median 18.9 vs. 17.4 years, p = .014). No differences in PTS existed for female recipients on the basis of gender‐match, DRWR, and gender/DRWR together (all p > .1).Conclusions: When considered together, gender and DRWR pairings impact PTS in male—but not female—pediatric heart transplant recipients. For males receiving ideal‐sized DRWR organs (most common pairing, >60%), male recipients achieve superior survival when female donor hearts are transplanted. These findings suggest that if weight is being used for size‐matching, donor gender should also be considered, particularly for male recipients.